AtriCure, Inc.
AtriCure, Inc.
Your view on ATRC
Overview
What the company does, where it operates, and who runs it.
About AtriCure, Inc.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Michael H. Carrel
- Headquarters
- 7555 Innovation Way, Mason, OH, US
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Michael H. Carrel
- Headquarters
- 7555 Innovation Way, Mason, OH, US
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally.
The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation.
It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes.
In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves.
It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
Stock Data
Price chart, volume, and trading data.
What moved it
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for AtriCure, Inc. from FRC's valuation model, read against the market price. ATRC last traded at $55.45, 184.6× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for AtriCure, Inc.. Starting points for AtriCure, Inc.: P/E 184.6, EPS $0.30, beta 1.21 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for AtriCure, Inc.. AtriCure, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for AtriCure, Inc.. Trailing twelve-month EPS for AtriCure, Inc. stands at $0.30. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$59.22
average of 9 firms, last 12 months
Analyst Ratings
- Strong Buy0
- Buy6
- Hold3
- Sell0
- Strong Sell0
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | -$0.01 | $0.03 | $0.23 | $0.47 |
| Low estimate | -$0.02 | -$0.07 | $0.15 | $0.37 |
| High estimate | $0.00 | $0.16 | $0.27 | $0.51 |
| No. of analysts | 5 | 4 | 6 | 7 |
| Year-ago EPS | $0.061 | $0.001 | -$0.241 | — |
| Growth | — | — | — | — |
1Year-ago EPS includes one-time items; growth not shown.
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $159.44M | $158.32M | $608.45M | $682.18M |
| Low estimate | $159.34M | $157.75M | $608.33M | $678.85M |
| High estimate | $159.65M | $159.25M | $608.73M | $684.34M |
| No. of analysts | 7 | 5 | 8 | 8 |
| Year-ago revenue | $140.50M | $141.25M | $534.53M | — |
| Growth | +13.5% | +12.1% | +13.8% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga; as of Nov 18, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for AtriCure, Inc.. AtriCure, Inc. has reported as a listed company since 2005. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- ADGMAdagio Medical Holdings, Inc.Medical - Devices$1M
- BSXBoston Scientific CorporationMedical - Devices$63.3B
- EWEdwards Lifesciences CorporationMedical - Devices$60.5B
- LIVNLivaNova PLCMedical - Devices$5.2B
- MDTMedtronic plcMedical - Devices$128.8B
More Medical - Instruments & Supplies companies
- VSMDVasamed, Inc.OTC$802
- WHSIWearable Health Solutions, Inc.OTC$182,671
- WSTWest Pharmaceutical Services, Inc.NYSE$28.1B
- XRAYDENTSPLY SIRONA Inc.NASDAQ$1.7B
- YBGJYubo International Biotech LimitedOTC$1M
- ZJYLJin Medical International Ltd.NASDAQ$26M
- SHWGYShandong Weigao Group Medical Polymer Company LimitedOTC$3.0B
- SMTISanara MedTech Inc.NASDAQ$301M
- SOAGYSartorius AGOTC$82.3B
- SOLVSolventum CorporationNYSE$14.7B
- SRTOYSartorius Stedim Biotech S.A.OTC$209.8B
- SSSGYSartorius AGOTC$15.8B
ETFs holding AtriCure, Inc.
% of the fund
- IJRiShares Core SP Small-Cap ETF$103.8B in assets0.16%
- IWMiShares Russell 2000 ETF$76.6B in assets0.10%
- VTIVanguard Total Stock Market ETF$689.2B in assets0.00%
- VBVanguard Small-Cap ETF$76.9B in assets0.04%
- XHEState Street SPDR S&P Health Care Equipment ETF$163M in assets1.62%
- PSCHInvesco S&P SmallCap Health Care ETF$188M in assets1.54%
- HAPSHarbor Human Capital Factor US Small Cap ETF (HAPS)$190M in assets1.51%
- PTHInvesco Dorsey Wright Healthcare Momentum ETF$293M in assets1.33%
Largest holders first, then the funds most concentrated in ATRC.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold AtriCure, Inc., and how their positions are changing. At a $2.82B market value, institutional positions materially move AtriCure, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by AtriCure, Inc. executives and directors. Shares of AtriCure, Inc. have traded between $28.29 and $43.11 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming AtriCure, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for AtriCure, Inc.. Coverage tracks AtriCure, Inc. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of AtriCure, Inc.